Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
12 Jan 2020
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Kids living in poverty lack sleep, physical activity

30 Oct 2019

Toddlers from families living in poverty are likely to not meet guidelines for physical activity and sleep, a recent study has found.

The study included 101 toddlers (mean age, 20.2±5.5 months; 61 percent male) from low-income families. Participants were made to wear ankle accelerometers for 24 hours over 3–7 consecutive days. Parent reports on wake/sleep patterns of their children were used to verify daytime napping data.

Toddlers slept for an average of 499.8 minutes per night, corresponding to approximately 8 hours of sleep. The average bed and wake times were 9:36 PM and 8:10 AM. Sleep efficiency was at 80 percent, and an average of 1.8 naps were taken daily, each lasting a mean of 67.2 minutes. Overall, 44 percent of the 24-hour day was spent sleeping.

In terms of activity, participants spent 172 minutes in sedentary behaviour, 54.5 minutes in moderate-to-vigorous physical activity (MVPA) and 579.8 minutes in light activity.

Only 32 percent of the participating toddlers met the recommendation of 11–14 hours of sleep within 24 hours, while only 26 percent met bedtime guidelines. Thirty-eight percent satisfied the preschool physical activity guideline of ≥60 minutes of MVPA.

Children living above the poverty line were significantly more likely to meet a greater number of sleep and activity guidelines than their counterparts (r, –0.229; p=0.02). Similarly, those who were not living in poverty were significantly more likely to fulfil the ≥60-minute MVPA daily requirement (odds ratio, 3.703, 95 percent CI, 1.455–9.428; p<0.05).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
12 Jan 2020
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.